Evidence mapPaperPMID 31886293Full record

ArticleJournal of diabetes research2019

Frequency of Gestational Diabetes Mellitus Reappearance or Absence during the Second Pregnancy of Women Treated at Mayo Clinic between 2013 and 2018.

Elizabeth Ann L Enninga, Aoife M Egan, Layan Alrahmani, Alexey A Leontovich, Rodrigo Ruano, Michael P Sarras

Open access · goldAbstract read
In one paragraph

Article in Journal of diabetes research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Multigenerational diabetes mellitus.Frontiers in endocrinology · 2023
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Elizabeth Ann L EnningaDepartment of Obstetrics and Gynecology, Mayo Clinic, 200 First Street SW, Rochester, MN, USA.ORCID https://orcid.org/0000-0003-3621-7335
Aoife M EganDepartment of Endocrinology, Mayo Clinic, 200 First Street SW, Rochester, MN, USA.
Layan AlrahmaniDepartment of Obstetrics and Gynecology, Mayo Clinic, 200 First Street SW, Rochester, MN, USA.ORCID https://orcid.org/0000-0002-9661-9291
Alexey A LeontovichDepartment of Health Science Research, Mayo Clinic, 200 First Street SW, Rochester, MN, USA.
Rodrigo RuanoDepartment of Obstetrics and Gynecology, Mayo Clinic, 200 First Street SW, Rochester, MN, USA.ORCID https://orcid.org/0000-0002-3642-5858
Michael P SarrasDepartment of Cell Biology and Anatomy, Rosalind Franklin University of Medicine and Science, 3333 Green Bay Road, N. Chicago, IL, USA.ORCID https://orcid.org/0000-0001-7151-527X
Mayo Clinic · USRosalind Franklin University of Medicine and Science · US

Funding

NICHD NIH HHS K12 HD065987NIDDK NIH HHS R21 DK092721
6 · The paper itself

Abstract

The Center for Disease Control and Prevention ranks diabetes mellitus (DM) as the seventh leading cause of death in the USA. The most prevalent forms of DM include Type 2 DM, Type 1 DM, and gestational diabetes mellitus (GDM). While the acute problem of diabetic hyperglycemia can be clinically managed through dietary control and lifestyle changes or pharmacological intervention with oral medications or insulin, long-term complications of the disease are associated with significant morbidity and mortality. These long-term complications involve nearly all organ systems of the body and share common pathologies associated with endothelial cell abnormalities. To better understand the molecular mechanisms underlying DM as related to future long-term complications following hyperglycemia, we have undertaken a study to determine the frequency that GDM did or did not occur in the second pregnancy of women who experienced GDM in their first pregnancy between 2013 and 2018 at Mayo Clinic, Rochester, MN. Within the five-year period of the study, the results indicate that 7,330 women received obstetrical care for pregnancy during the study period. Of these, 150 developed GDM in their first pregnancy and of these, 42 (28%) had a second pregnancy. Of these 42 women, 20 again developed GDM and 22 did not develop GDM in their second pregnancy within the study period. Following the occurrence of GDM in the first pregnancy, the study (1) established the number of women with and without GDM in the second pregnancy and (2) confirmed the feasibility to study diabetic metabolic memory using maternal placental tissue from GDM women. These studies represent Phase I of a larger research project whose goal is to analyze epigenetic mechanisms underlying true diabetic metabolic memory using endothelial cells isolated from the maternal placenta of women with and without GDM as described in this article.

Indexed as

ParityAdultBiomarkersBlood GlucoseDiabetes, GestationalEpigenesis, GeneticFemaleHumansMinnesotaPregnancyRecurrenceRisk FactorsTime FactorsYoung AdultBiomarkersBlood Glucose

Identifiers

PMID31886293
PMCPMC6893262
OpenAlexW2990111938

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.